Rat extracorporeal circulation model for evaluation of systemic immunotoxicity

Toxicology Letters

Volumn 115, Issue 1, 2000, Pages 63-70

  Adachi, Tomoko ^a   Mogi, Makio ^b   Furuya, Mami ^a   Kojima, Kohichi ^a  

^a HATANO RESEARCH INSTITUTE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Extracorporeal circulation; IgG; Tumor necrosis factor

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENT; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; POLYACRYLONITRILE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; COMPLEMENT HEMOLYSIS TEST; DEVICE; DIALYSIS MEMBRANE; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; COMPLEMENT C3; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; EQUIPMENT AND SUPPLIES; EVALUATION STUDIES; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; LYMPHOCYTES; MEMBRANES, ARTIFICIAL; RATS; RATS, SPRAGUE-DAWLEY; RENAL DIALYSIS; TOXICITY TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034630340     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(00)00175-2     Document Type: Article

References (27)

1. Adachi T., Mogi M., Harada M., Kojima K. Selective removal of immunoglobulin E from rat blood by membrane-immobilized antibody. J. Chromatogr. B. 668:1995;327-332.
2. Adachi T., Mogi M., Harada M., Kojima K. Selective removal of human amyloid P component from rat blood by use of an immunoaffinity membrane in an extracorporeal circulation system. J. Chromatogr. B. 682:1996;47-54.
3. Chanard J., Bindi P., Lavaud S., Toupance O., Maheut H., Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br. Med. J. 298:1996;867-868.
4. Chenoweth D.E., Cheung A.K., Ward D.M., Henderson L.W. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int. 24:1983;770-774.
5. Colton C.K., Ward R.A., Shaldon S. Scientific basis for assessment of biocompatibility in extracorporeal blood treatment. Nephrol. Dial. Transplant. 9:1994;11-17.
6. Hakim R.M., Fearon D.T., Lazarus J.M. Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int. 26:1984;194-200.
7. 2-microglobulin levels in chronic hemodialysis patients. J. Am. Soc. Nephrol. 7:1996;472-478.
8. Hancock W.H., Whitley W.D., Tullius S.G., Heemann U.W., Wasowska B., Baldwin W.M., Tilney N.L. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation. 56:1993;643-650.
9. Herbelin A., Thu Nguyen A., Zingraff J., Urena P., Deschamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor-α Kidney Int. 37:1990;116-125.
10. Jadoul M., Noel H., van Ypersele de Strihou C. Beta-2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 15:1990;86-88.
11. Kehrl J.H., Miller A., Fauci A.S. Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J. Exp. Med. 166:1987;786-791.
12. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 87:1996;811-822.
13. Lonnemann G., Van Der Meer J.W., Cannon J.G., Dinarello C.A., Koch K.M., Granolleras C., Deschodt G., Shaldon S. Induction of tumor necrosis factor during extracorporeal blood purification. N. Engl. J. Med. 317:1987;963-964.
14. Luger A., Kovarik J., Stummvoll H.K., Urbanska A., Luger T.A. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int. 32:1987;84-88.
15. Ming W.J., Bersani L., Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138:1987;1469-1474.
16. 2-microglobulin from human plasma by high-performance immunoaffinity chromatography. J. Chromatogr. B. 496:1989;194-200.
17. 2-microglobulin from plasma specimens of long-term hemodialysis patients by high-performance immunoaffinity chromatography. Clin. Chem. 39:1993;277-280.
18. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. Tumor necrosis factor-α(TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165:1994;208-210.
19. Mulvihill J., Cazenave J.P., Mazzucotelli J.P., Crost T., Collier C., Renaux J.L., Pusineri C. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. Biomaterials. 13:1992;527-536.
20. Petruska J.M., Leslie K.O., Mossman B.T. Enhanced lipid peroxidation in lung lavage of rats after inhalation of asbestos. Free Rad. Biol. Med. 11:1991;425-432.
21. Pizarro T.T., Malinowska K., Kovacs E.J., Clancy J. Jr, Robinson J.A., Piccinini L.A. Induction of TNFα and TNFβ gene expression in rat cardiac transplants during allograft rejection. Transplantation. 56:1993;399-404.
22. Rodgers K., Klykeen P., Jacobs J., Frondoza C., Tomazic V., Zelikoff J. Immunotoxicity of medical devices. Fundam. Appl. Toxicol. 36:1997;1-14.
23. Steffen M., Ottmann O.G., Moore M.A.S. Simultaneous production of tumor necrosis factor-α and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J. Immunol. 140:1988;2621-2624.
24. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R., Fahey T.J., Zentella A., Albert J.D., Shires G.T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
25. Van Loveren H., Vos J.G. Immunotoxicological considerations: a practical approach to immunotoxicity testing in the rat. Dayan A.D., Paine A.J. Advances in Applied Toxicology. 1989;143-165 Taylor and Francis, London.
26. Wardle E.N., Piercy D.A. Studies of contact activation of blood in haemodialysis. J. Clin. Pathol. 25:1972;1045-1049.
27. Wyman J.F., Moore T.J., Buring M.S. Simple procedure for jugular vein cannulation of rats. Toxicol. Method. 4:1994;12-18.